Stem Cell

(Image: Getty/CIPhotos)

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.

Image: iStock/cacaroot

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

By Dan Stanton

Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

The heart muscle cells and connective tissue cells were generated from induced pluripotent stem cells. (Image: Nathaniel Huebsch, PhD)

Stem cells form tiny beating heart for drug testing

By Melissa Fassbender

While there are currently several techniques for producing tissue from heart cells, a new method reduces the amount of cells needed, making it easier and cheaper to replicate.

Japan’s PuRec to supply mesenchymal stem cells

Japan’s PuRec to supply mesenchymal stem cells

By Wang Fangqing

Regenerative medicine developers now have a new supplier for mesenchymal stem cells (MSCs), the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue repair.

apceth expands gene, cell therapy manufacturing business

apceth expands gene, cell therapy manufacturing business

By Zachary Brennan

German-based contract manufacturer apceth has received regulatory approval to use two new GMP cleanrooms for aseptic processing, which will be used for the handling and genetic manipulation of various types of cell and gene therapies. 

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers